Dr. Vinod Mittal, Senior Diabetologist, Delhi Heart and Lung Institute, will talk about the medications which are safe in diabetes kidney disease in this video. In diabetes kidney disease patients, sulphonylureas are avoided. The safest sulphonylureas given is glipizide which is short acting and other is gliclazide. Metformin can be continued till the eGFR is 30. He will further discuss the dose but will also highlight that all sulphonylureas should be avoided.
A disciplined, dedicated and a very competent senior diabetologist. Private practice for more than 20 years with special interest in diabetes care, education, and research. Director of Delhi Diabetes Care Center located in Karol Bagh (Delhi). He is a Senior Consultant Diabetologist at Delhi Heart & Lung Institute.
Subscribe To Our Newsletter
Filter out the noise and nurture your inbox with health and wellness advice that's inclusive and rooted in medical expertise.
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please update your details
Please login to comment on this article